← All organizations
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2012Last known activity
Jan 1, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 3 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (2 own, 0 via acquisition)
Other trials (7 own, 0 via acquisition)
Indications
Recent trials (5)
- NCT04931615Study chairPhase 4Jan 1, 2022
- NCT04931615Lead sponsorPhase 4Jan 1, 2022
- NCT02578394CollaboratorPhase 2/Phase 3Apr 1, 2016
- NCT01666587Lead sponsorN/AAug 1, 2012
- NCT01666587Reponsible party - principal investigatorN/AAug 1, 2012
Details
- Last known activity
- Jan 1, 2022